Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer.
| Image |  |
|---|---|
| Description | scientific article published on 14 August 2014 |
| Author/s |
author: Eva M Ciruelos |
| Publication date | August 14, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |